|
1
|
Krcova Z, Ehrmann J, Krejci V, Eliopoulos
A and Kolar Z: Tpl-2/Cot and COX-2 in breast cancer. Biomed Pap Med
Fac Univ Palacky Olomouc Czech Repub. 152:21–25. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jezierska A and Motyl T: Matrix
metalloproteinase-2 involvement in breast cancer progression: a
mini-review. Med Sci Monit. 15:RA32–RA40. 2009.PubMed/NCBI
|
|
3
|
Gasparini G: Therapy of breast cancer with
molecular targeting agents. Ann Oncol. 16:iv28–iv36. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Osborne C, Wilson P and Tripathy D:
Oncogenes and tumor suppressor genes in breast cancer: potential
diagnostic and therapeutic applications. Oncologist. 9:361–377.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Su ZZ, Kang DC, Chen YM, et al:
Identification and cloning of human astrocyte genes displaying
elevated expression after infection with HIV-1 or exposure to HIV-1
envelope glycoprotein by rapid subtraction hybridization, RaSH.
Oncogene. 21:3592–3602. 2002. View Article : Google Scholar
|
|
6
|
Hu G, Wei Y and Kang Y: The multifaceted
role of MTDH/AEG-1 in cancer progression. Clin Cancer Res.
15:5615–5620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Zhang N, Song LB, et al: Astrocyte
elevated gene-1 is a novel prognostic marker for breast cancer
progression and overall patient survival. Clin Cancer Res.
14:3319–3326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kang D, Su Z, Sarkar D, Emdad L, Volsky D
and Fisher P: Cloning and characterization of HIV-1-inducible
astrocyte elevated gene-1, AEG-1. Gene. 353:8–15. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brown DM and Ruoslahti E: Metadherin, a
cell surface protein in breast tumors that mediates lung
metastasis. Cancer Cell. 5:365–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu G, Chong R, Yang Q, et al: MTDH
activation by 8q22 genomic gain promotes chemoresistance and
metastasis of poor-prognosis breast cancer. Cancer Cell. 15:9–20.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Su Z: Customized rapid subtraction
hybridization (RaSH) gene microarrays identify overlapping
expression changes in human fetal astrocytes resulting from human
immunodeficiency virus-1 infection or tumor necrosis factor-α
treatment. Gene. 306:67–78. 2003.
|
|
12
|
Emdad L: Activation of the nuclear factor
κB pathway by astrocyte elevated gene-1: implications for tumor
progression and metastasis. Cancer Res. 66:1509–1516. 2006.
|
|
13
|
Thirkettle HJ, Girling J, Warren AY, et
al: LYRIC/AEG-1 is targeted to different subcellular compartments
by ubiquitinylation and intrinsic nuclear localization signals.
Clin Cancer Res. 15:3003–3013. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu RC, Qin J, Hashimoto Y, et al:
Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator
activity by IκB kinase. Mol Cell Biol. 22:3549–3561.
2002.PubMed/NCBI
|
|
15
|
Lee SG, Su ZZ, Emdad L, Sarkar D and
Fisher PB: Astrocyte elevated gene-1 (AEG-1) is a target gene of
oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc.
Proc Natl Acad Sci USA. 103:17390–17395. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee SG, Jeon HY, Su ZZ, et al: Astrocyte
elevated gene-1 contributes to the pathogenesis of neuroblastoma.
Oncogene. 28:2476–2484. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thirkettle HJ, Mills IG, Whitaker HC and
Neal DE: Nuclear LYRIC/AEG-1 interacts with PLZF and relieves
PLZF-mediated repression. Oncogene. 28:3663–3670. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ
and Fisher PB: Molecular basis of nuclear factor-κB activation by
astrocyte elevated gene-1. Cancer Res. 68:1478–1484. 2008.
|
|
19
|
Yoo BK, Emdad L, Su ZZ, et al: Astrocyte
elevated gene-1 regulates hepatocellular carcinoma development and
progression. J Clin Invest. 119:465–477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kikuno N, Shiina H, Urakami S, et al:
Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer
progression through upregulation of FOXO3a activity. Oncogene.
26:7647–7655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khuda II, Koide N, Noman AS, et al:
Astrocyte elevated gene-1 (AEG-1) is induced by lipopolysaccharide
as toll-like receptor 4 (TLR4) ligand and regulates TLR4
signalling. Immunology. 128:e700–e706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee SG, Su ZZ, Emdad L, Sarkar D, Franke
TF and Fisher PB: Astrocyte elevated gene-1 activates cell survival
pathways through PI3K-Akt signaling. Oncogene. 27:1114–1121.
2007.PubMed/NCBI
|
|
23
|
Yu C, Chen K, Zheng H, et al:
Overexpression of astrocyte elevated gene-1 (AEG-1) is associated
with esophageal squamous cell carcinoma (ESCC) progression and
pathogenesis. Carcinogenesis. 30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Emdad L, Lee SG, Su ZZ, et al: Astrocyte
elevated gene-1 (AEG-1) functions as an oncogene and regulates
angiogenesis. Proc Natl Acad Sci USA. 106:21300–21305. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Doerfler W, Hohlwey U, Müller K, Remus R,
Heller H and Hertz J: Foreign DNA integration perturbations of the
genome oncogenesis. Ann NY Acad Sci. 945:276–288. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Yang L, Song L, et al: Astrocyte
elevated gene-1 is a proliferation promoter in breast cancer via
suppressing transcriptional factor FOXO1. Oncogene. 28:3188–3196.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu JM, Yuan Y, Huan J and Shen ZY:
Inhibition of breast and brain cancer cell growth by BCCIPalpha, an
evolutionarily conserved nuclear protein that interacts with BRCA2.
Oncogene. 20:336–345. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meng XB, Lu HM and Shen ZY: BCCIP
functions through p53 to regulate the expression of p21Waf1/Cip1.
Cell Cycle. 3:1457–1462. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ash S, Yang D and Britt D: LYRIC/AEG-1
overexpression modulates BCCIPα protein levels in prostate tumor
cells. Biochem Biophys Res Commun. 371:333–338. 2008.PubMed/NCBI
|
|
30
|
Meng X, Fan J and Shen Z: Roles of BCCIP
in chromosome stability and cytokinesis. Oncogene. 26:6253–6260.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Emdad L, Sarkar D, Su Z, et al: Astrocyte
elevated gene-1: recent insights into a novel gene involved in
tumor progression, metastasis and neurodegeneration. Pharmacol
Ther. 114:155–170. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kunnumakkara A, Anand P and Aggarwal B:
Curcumin inhibits proliferation, invasion, angiogenesis and
metastasis of different cancers through interaction with multiple
cell signaling proteins. Cancer Lett. 269:199–225. 2008. View Article : Google Scholar
|
|
33
|
Qiao M, Sheng SJ and Pardee AB: Metastasis
and Akt activation. Cell Cycle. 7:2991–2996. 2008. View Article : Google Scholar
|
|
34
|
Cao Y: Opinion: emerging mechanisms of
tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer.
5:735–743. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu L, Wu J, Ying Z, et al: Astrocyte
elevated gene-1 upregulates matrix metalloproteinase-9 and induces
human glioma invasion. Cancer Res. 70:3750–3759. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
37
|
Matsuo Y, Ochi N, Sawai H, et al:
CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness
and angiogenesis in pancreatic cancer. Int J Cancer. 124:853–861.
2009.PubMed/NCBI
|
|
38
|
Kuwano T: Cyclooxygenase 2 is a key enzyme
for inflammatory cytokine-induced angiogenesis. FASEB J.
18:300–310. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Marrogi A, Travis W, Welsh J, et al:
Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial
growth factor in the angiogenesis of non-small cell lung carcinoma.
Clin Cancer Res. 6:4739–4744. 2000.PubMed/NCBI
|
|
40
|
Liu H, Song X, Liu C, Xie L, Wei L and Sun
R: Knockdown of astrocyte elevated gene-1 inhibits proliferation
and enhancing chemo-sensitivity to cisplatin or doxorubicin in
neuroblastoma cells. J Exp Clin Cancer Res. 28:192009. View Article : Google Scholar
|
|
41
|
Lerebours F, Vacher S, Andrieu C, et al:
NF-kappa B genes have a major role in inflammatory breast cancer.
BMC Cancer. 8:412008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yoo BK, Gredler R, Vozhilla N, et al:
Identification of genes conferring resistance to 5-fluorouracil.
Proc Natl Acad Sci USA. 106:12938–12943. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yoo BK, Chen D, Su ZZ, et al: Molecular
mechanism of chemoresistance by astrocyte elevated gene-1. Cancer
Res. 70:3249–3258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim DH, Mohapatra G, Bollen A, Waldman FM
and Feuerstein BG: Chromosomal abnormalities in glioblastoma
multiforme tumors and glioma cell lines detected by comparative
genomic hybridization. Int J Cancer. 60:812–819. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ried TJK, Holtgreve-Grez H, et al:
Comparative genomic hybridization of formalin-fixed,
paraffin-embedded breast tumors reveals different patterns of
chromosomal gains and losses in fibroadenomas and diploid and
aneuploid carcinomas. Cancer Res. 55:5415–5423. 1995.
|
|
46
|
Bergamaschi A, Kim YH, Wang P, et al:
Distinct patterns of DNA copy number alteration are associated with
different clinicopathological features and gene-expression subtypes
of breast cancer. Genes Chromosomes Cancer. 45:1033–1040. 2006.
View Article : Google Scholar
|
|
47
|
Warr T, Ward S, Burrows J, et al:
Identification of extensive genomic loss and gain by comparative
genomic hybridisation in malignant astrocytoma in children and
young adults. Genes Chromosomes Cancer. 31:15–22. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sarkar D, Emdad L, Lee SG, Yoo BK, Su ZZ
and Fisher PB: Astrocyte elevated gene-1: far more than just a gene
regulated in astrocytes. Cancer Res. 69:8529–8535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Trimboli AJ, Fukino K, de Bruin A, et al:
Direct evidence for epithelial-mesenchymal transitions in breast
cancer. Cancer Res. 68:937–945. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Radisky ES and Radisky DC: Matrix
metalloproteinase-induced epithelial-mesenchymal transition in
breast cancer. J Mammary Gland Biol Neoplasia. 15:201–212. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Britt D, Yang D, Flanagan D, et al:
Identification of a novel protein, LYRIC, localized to tight
junctions of polarized epithelial cells. Exp Cell Res. 300:134–148.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Itoh M and Bissell MJ: The organization of
tight junctions in epithelia: implications for mammary gland
biology and breast tumorigenesis. J Mammary Gland Biol Neoplasia.
8:449–462. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ikenouchi J: Regulation of tight junctions
during the epithelium-mesenchyme transition: direct repression of
the gene expression of claudins/occludin by Snail. J Cell Sci.
116:1959–1967. 2003. View Article : Google Scholar : PubMed/NCBI
|
